Thesis (Ph. D.)--University of Missouri--Columbia, 1996. / "December 1996." Typescript. Vita. Includes bibliographical references (leaves 196-206). Also available on the Internet.

In 1993, Novak and Tyson published a comprehensive mathematical model of the regulation of M-phase promoting factor (MPF) activity in Xenopus laevis eggs and egg extracts. Although this model was in agreement with existing and subsequent experimental data, fundamental predictions that the cell cycle is driven by a hysteresis loop have never been validated experimentally. The model's predictions of bifurcations that create and destroy MPF activity, indicative of hysteresis, were tested in this study. <u>Prediction 1: The threshold concentration of cyclin B required to activate MPF is measurably higher than the threshold concentration required to inactivate MPF.</u> The difference in thresholds implies that the MPF control system is hysteretic and bistable. To measure these thresholds, extracts in interphase or M-phase were supplemented with varying concentrations of non-degradable human cyclin B1 protein. MPF activity was determined by the morphology of sperm nuclei and by assays of histone H1 kinase activity. Consistent with the model, the activation threshold was determined to be 40 nM, which is two-fold higher than the inactivation threshold, 20 nM. <u>Prediction 2: For cyclin levels marginally above the activation threshold concentration of cyclin B, there is a dramatic "slowing-down" in the rate of MPF activation.</u> Supra-threshold concentrations of nondegradable cyclin B1 were added to cycloheximide-treated CSF-released extracts, and samples taken at various time-points were analyzed for MPF activity. At 40 nM cyclin B1, just above the activation threshold, the lag time for MPF activation was 45 - 60 minutes; at 50 nM cyclin B1, the lag time was between 30 - 45 minutes; and at 60 nM or higher concentrations of cyclin B1, the lag time was 20 - 30 minutes, thus confirming the prediction of the Novak-Tyson model. <u>Prediction 3: DNA replication checkpoint increases the activation threshold concentration of cyclin B by increasing the hysteresis loop.</u> Cycloheximide-treated, CSF-released extracts containing 1200 sperm nuclei/&#956;l were treated with aphidicolin, then supplemented with varying concentrations of nondegradable cyclin B1. The activation threshold was 100 nM, 2.5 fold higher than in extracts lacking aphidicolin. <u>Conclusions:</u> These studies confirm three predictions of the Novak-Tyson model and indicate that hysteresis underlies cell cycle control in Xenopus egg extracts. These experiments validate use of mathematical models to study complex biological control systems such as the eukayotic cell cycle. / Master of Science

Initiation of postembryonic development is an important event for normal C. elegans development. Extrinsic factors affect development as well as intrinsic developmental cues. In order to investigate the molecular basis of initiation of postembryonic development, a genetic screen was performed to identify temperature-sensitive mutants that cannot initiate the cell divisions associated with postembryonic development at the restrictive temperature. Hydroxyurea (HU), a DNA replication inhibitor, was used as a tool to select against worms that initiate postembryonic cell divisions and/or the developmental program. 1,600,000 haploid genomes were screened, and 20 mutants have been isolated. 6 of them have been mapped to a relatively small genetic interval, and one inx-6 has been cloned and encodes an innexin family protein. Mutation of inx-6 caused abnormalities in pharyngeal pumping, resulting in worms that could not feed. The functions of a cyclin B homologue (ZC168.4) in postembryonic development have also been studied since cyclin B mutants also have postembryonic developmental arrest phenotype. Results indicate that zygotic expression of cyclin B is absolutely required for normal postembryonic development. Moreover, we found a novel function of this cyclin B homologue, which demonstrates an uncommon paternal effect required for spermatogenesis and/or fertilization.

Thesis (Ph. D.)--University of Missouri--Columbia, 1996. / Typescript. Vita. Includes bibliographical references (leaves: 196-206). Also available on the Internet.

No description available.

Most cellular proteins retain a stable concentration as cells grow and divide, but there are exceptions. Some cell cycle regulators change in concentration with cell size. In fission yeast, Cdc13 (cyclin B), an important activator of the core cell cycle kinase Cdc2 (CDK1), increases in concentration as cells grow. It has been proposed that the concentration of such cell cycle regulators serves as a proxy for cell size and makes cell cycle progression dependent on cell size, thereby contributing to cell size homeostasis. The underlying mechanisms for the size-dependent scaling of these cell cycle regulators are poorly understood. Here, I show that Cdc13 protein concentration, but not mRNA concentration, increases with cell size. Furthermore, only the nuclear, but not the cytoplasmic, fraction of Cdc13 increases in concentration as cell size increases. Computational modeling along with half-life measurements suggests that stabilization of Cdc13 in the nucleus plays an important role in establishing this pattern. Taken together, my results suggest that Cdc13 scales with time, and therefore only indirectly—not directly—with cell size. This leaves open the possibility that Cdc13 contributes to cell size homeostasis, but in a different way than originally proposed. / Master of Science / Cells maintain their size very efficiently, but how they manage to do so is not well characterized. It has been suggested that cells sense their size by the size-dependent concentration changes of cell cycle proteins. I have investigated how cyclin B may serve as such a proxy for cell size in fission yeast. My data suggest that fission yeast cyclin B indirectly scales with cell size through an unknown time-based mechanism.

Activation of the MAPK cascade during mitosis is critical for spindle assembly and normal mitotic progression. The underlying regulatory mechanisms that control activation of the MEK/MAPK cascade during mitosis are poorly understood. The goal of my dissertation research is to identify the MEK kinase responsible for activation of the MAPK cascade during mitosis and to elucidate the biochemical mechanisms that regulate its activity. In the described herein work I purified and characterized the MEK kinase activity present in M-phase arrested Xenopus egg extracts. I demonstrate that B-Raf is the critical MEK kinase required for activation of the MAPK pathway at mitosis. Consistent with this, I show that B-Raf is activated in an M-phase dependent manner. Further, I provide data linking Cdk1/cyclin B to mitotic activation of B-Raf. Cdk1/cyclin B associates with and phosphorylates B-Raf in M-phase arrested extracts and directly targets Xenopus B-Raf in vitro at a conserved Ser-144 residue. Phosphorylation at Ser-144 is critical for M-phase dependent activation of B-Raf and for B-Raf's ability to trigger activation of the MAPK cascade at mitosis. Finally, I demonstrate that mitotic B-Raf undergoes feedback phosphorylation by MAPK at its conserved C-terminal SPKTP motif. Mutation of both phosphorylation sites within the SPKTP sequence to alanines increases activity of mitotic B-Raf. Further, inhibition or over-activation of MAPK during mitosis enhances or diminishes B-Raf activity, respectively. These results indicate that MAPK-mediated feedback phosphorylation negatively regulates B-Raf activity. Additionally, I show that active mitotic B-Raf exists in large multi-protein complex(s). By utilizing a proteomics approach I identify a set of proteins, which potentially associate with B-Raf at M-phase. Future studies are necessary to elucidate the involvement of these proteins in regulating B-Raf mitotic functions. In summary, my dissertation studies demonstrate that B-Raf activates MAPK signaling at mitosis and undergoes an M-phase dependent regulation. I propose that B-Raf has important functions at mitosis that contributes to its overall role in promoting cell proliferation.

<p>Post-transcriptional regulation plays an important role in governing various processes in all organisms. The development of the early embryo of <italic>Drosophila melanogaster</italic> is governed solely by post-transcriptional mechanisms; therefore, further insights into post-transcriptional regulation can be gained by studying the <italic>Drosophila </italic> embryo. This thesis addresses the actions of the translational repressor, Pumilio, in regulating two mRNAs during early embryogenesis. First, we examined the ability of Pumilio to regulate the mRNA stability of <italic>bicoid</italic>, a gene required for <italic>Drosophila </italic> head development. <italic>bicoid</italic> mRNA contains the canonical Pumilio recognition site, termed the Nanos response element (NRE), within the 3'UTR. Interestingly, we show that Pumilio binds to the NRE both in vitro and in vivo; however, no physiological significance is associated with this interaction. Furthermore, in <italic> pumilio</italic> mutant embryos <italic>bicoid</italic> mRNA stability and translation are unaltered, demonstrating that Pumilio does not regulate <italic>bicoid</italic> mRNA. Second, Pumilio has been shown to negatively regulate <italic>Cyclin B</italic>, the cyclin necessary for mitotic entry, in the somatic cytoplasm of the embryo and this repression is alleviated by the PNG Kinase complex through currently unidentified mechanisms. We further investigated the actions of Pumilio in regulating <italic>Cyclin B</italic> and discovered that the canonical partner of Pumilio, Nanos, is not involved in repressing somatic <italic>Cyclin B</italic>. Furthermore, we show that the 3'UTR of <italic>Cyclin B</italic> is not required for the regulation by Pumilio and the PNG Kinase complex. Lastly, through genetic analyses, we conclude that Pumilio may actually act upstream of the PNG Kinase complex to regulate <italic>Cyclin B</italic>.</p> / Dissertation

Une surprolifération cellulaire associée à de l’aneuploïdie est un marqueur couramment retrouvé dans les cancers et une faible instabilité génétique peut-être un élément aggravant (sinon déclencheur) de la tumorigénèse. Récemment, il a été montré sur un modèle de cellules cancéreuses en culture qu’une forte aneuploïdie compromet la prolifération cellulaire en entraînant la mort de ces dernières. Au cours de ma thèse, nous avons souhaité tester si cette hypothèse se vérifiait in vivo en utilisant comme modèle, les tumeurs du système nerveux central de la larve de D. melanogaster. Nous avons fait le choix d’utiliser des mutants pour des gènes impliqués dans la formation du fuseau mitotique et la ségrégation des chromosomes (Sas-4 ou AurA) afin d’induire ces tumeurs. Pour générer l’aneuploïdie, nous avons choisi d’associer les mutations sas-4 ou aurA avec des mutations pour des gènes essentiels du SAC, Mad2 ou BubR1ken. Nous avons ensuite analysé par immunofluorescence et microscopie l’effet de la perte du SAC sur la prolifération des Nb. Pour sas-4, la perte du SAC cause l’apparition d’une forte aneuploïdie et une baisse du nombre de Nb associée à une forte réduction de taille des cerveaux. Cela compromet totalement la capacité des cerveaux mutants à induire des tumeurs lorsqu’on les injecte dans l’abdomen de mouches adultes saines. Dans le cas d’aurA, ni hausse de l’aneuploïdie dans le tissu ni baisse de la prolifération des Nbs n’ont été observés. Par ailleurs, la même forte proportion de mouches injectées avec des cerveaux aurA ou aurA mad2 développant une tumeur a été constaté. Afin de mieux comprendre pourquoi le mutant aurA ne réagit pas comme le mutant sas-4 à la déplétion du SAC, nous avons entrepris une analyse détaillée des mutants aurA et aurA mad2. Nous avons d’abord observé que, malgré la perte du SAC, 1) il existe toujours un délai en mitose dans aurA mad2 et 2) il existe un délai entre la satisfaction du SAC et l’entrée en anaphase dans aurA. Comme l’entrée en anaphase est dépendante de la dégradation de la CycB et de la Sécurine via l’APC/C, nous avons analysé le comportement de la CycB (couplé à une étiquette GFP) par vidéo-microscopie en temps réel et observé un défaut de la régulation de la dégradation de cette dernière dans le mutant aurA ainsi que dans le double mutant aurA mad2. Ces observations nous ont permis de proposer un nouveau rôle pour la kinase AurA dans la régulation de la dégradation de la CycB en fin de mitose. / Cellular overproliferation associated with aneuploidy is a common hallmark of cancers. Low genetic instability may be a contributing factor of tumorigenesis. Recently, it was shown on a cellular cancer model in culture that strong aneuploidy compromises cell proliferation by causing cell death. During my thesis, we have test if this hypothesis was verified in vivo by using as a model, the tumours of the larval central nervous system of D. melanogaster. We decided to use mutants involved in mitotic spindle formation and chromosome segregation (Sas-4 or AurA) to induce these tumours. To generate aneuploidy, we chose to associate these mutations with mutations in genes essential for the SAC, Mad2 or BubR1ken. We then analysed the effect of the SAC depletion on the Nb proliferation. For sas-4, loss of the SAC leads to high aneuploidy and a decrease in Nb number associated with brain size reduction. It completely undermines the ability of mutant brain to induce tumors when injected into the abdomen of healthy adult flies. In the case of aurA, nor increase of aneuploidy in tissue or decrease in nb proliferation have been observed. Moreover, the same proportion of flies injected with aurA or aurA mad2 brains developed tumours. To better understand why the aurA mutant not react as the sas-4 mutant to the SAC depletion, we undertook a detailed analysis of aurA and aurA mad2 mutants. We first observed that despite the SAC depletion, 1) there is always a delay in mitosis in aurA mad2 and 2) there is a delay between SAC satisfaction and anaphase onset in aurA. Since anaphase onset is dependent of the CycB and Securine degradation via the APC / C, we analysed the behaviour of the CycB (coupled with a GFP tag) by real-time videomicroscopy and observed a defect in the regulation of CycB degradation in aurA and in the double aurA mad2 mutant. These observations lead us to propose a new role for AurA kinase in regulating the degradation of CycB at the end of mitosis.

HHV-6 is a ubiquitous human herpesvirus. Most individuals become infected at the age of 2 years. Primary infection by the virus causes a self-limiting febrile illness called exanthem subitum or roseola. In adults, primary infection may cause mononucleosis-like illnesses. The infection usually remains latent in healthy individuals, but often reactivates in immunocompromised individuals, for example, transplant patients and AIDS patients. The virus has also been associated with cancers and lymphoproliferative disorders. The virus encodes two proteins that interact with p53. However, little is known concerning the impact of the virus on cell cycle progression in human cells. The investigations reported in the thesis were focused on this issue. We show here that that HHV-6 infection delays the cell cycle progression in human T cell line HSB-2, as well as in primary human T cells and causes their accumulation in S and G2/M phase. By degrading the viral DNA in the virus-infected cells, we show that the infected cells accumulate in the G2/M and not in the S phase. We observed an increase in the kinase activity of cdc2 in virus-infected cells despite lower levels of its catalytic partners, cyclin A and cyclin B. We show here that the viral early antigen p41 associates with, and increases the kinase activity of, CDK1. Our studies have shown that there is a drastic reduction of p21 protein, despite the virus-induced stabilization and activation of p53 suggesting that p53 may be transcriptionally inactivated in the virus-infected cells. This decrease of p21 in infected cells was partially restored by proteasome inhibitors. These results suggest that HHV-6 causes perturbations in the normal progression of cell cycle in human T cells. Autophagy is a physiological cell process during which old cellular constituents and long-lived proteins in cells are degraded. This process is regulated in a cell cycle-dependent manner. We show here that infection with HHV-6 induces autophagy in HSB-2 cells. This was shown by the induction of LC-3 II as well as by the appearance of autophagic vacuoles in the virus-infected cells. However, we found that the virus inhibits fusion between autophagic vacuoles and lysosomes formed in infected cells, thus evading the autophagic response of infected host cells. Finally we tried to investigate replication of the virus in human cells in the absence of P53; a tumor suppressor gene which is also known as "the guardian of the genome ". During these investigations, we found that that inhibition of p53 gene expression mediated by siRNA as well as its inhibition by pharmacological inhibitors leads to massive cell death in human T cell line HSB-2 that carries a wild-type p53. We show that this death also occurs in another cell line CEM, which carries a transcriptionally mutated p53. Interestingly, the cell death could be prevented by pharmacological inhibitors of autophagy and necroptosis. Taken together, our results provide important novel insights concerning the impact of HHV-6 on cell cycle regulation and autophagy as well as of basal level p53 in cell survival. / HHV-6 est un virus herpès humain ubiquitaire. La plupart des individus deviennent séropositifs à l’âge de 2 ans. L’infection primaire par HHV-6 donne lieu à une maladie fébrile chez les enfants, appelée exanthème subitum ou la roséole. Par contre, chez l'adulte, cette infection cause des maladies de type mononucléose. L'infection reste généralement latente chez les individus sains, mais elle se réactive souvent chez les personnes immunodéprimées, par exemple, chez les personnes greffées et les patients atteints du sida. HHV-6 a été associé à plusieurs types de cancers et de désordres lymphoprolifératifs. Ce virus induit l’immunosuppression et inhibe la prolifération des lymphocytes par les mitogènes. C’est pour toutes ces raisons que nous voulions savoir si ce virus dérègle le cycle cellulaire des cellules qu’il infecte. Les travaux réalisés durant cette thèse ont porté sur les changements induits dans les cellules humaines par ce virus au cours de la progression du cycle cellulaire. Nous avons montré que l'infection par HHV-6 retarde la progression du cycle cellulaire dans la lignée cellulaire T humaine HSB-2, ainsi que dans les lymphocytes T primaires humains pour les accumuler dans les phases S et G2/M. Cependant, après avoir traité les cellules avec la nucléase du Micrococcus, nous avons constaté que le cycle cellulaire des cellules infectées s’accumulait plutôt dans la phase G2/M. La nucléase dégrade préférentiellement l’ADN virale. Nous avons observé une augmentation de l'activité kinase de cdc2 dans les cellules infectées malgré une baisse des niveaux de ses partenaires catalytiques, la cycline A et la cycline B. Nos études ont montré qu’il y a une diminution drastique de la protéine p21 dans les cellules infectées, en dépit de la stabilisation et de l'activation de p53 induite dans ces cellules. Ce qui laisse penser que la protéine p53 pourrait être inactive sur le plan transcriptionnel dans les cellules infectées. Cette diminution de p21 dans les cellules infectées est partiellement restaurée après incubation des cellules dans un milieu de culture contenant des inhibiteurs du protéasome. En plus, nous démontrons ici qu’une protéine virale précoce, p41, s’associe et se fixe avec cdc2 et augmente son activité kinase. Tous ces résultats suggèrent que HHV-6 provoque des perturbations énormes dans la progression normale du cycle cellulaire dans les cellules T humaines. Dans ces études, nous avons démontré aussi que l’infection par HHV-6 induit l'autophagie dans les cellules HSB-2, comme il a été démontré par l’induction de LC-3 II et par la formation de vacuoles autophagiques dans les cellules qui sont infectées. Nos résultats indiquent que HHV-6 inhibe la fusion entre les vacuoles autophagiques formées et les lysosomes dans les cellules infectées modulant ainsi la réponse autophagique des cellules hôtes infectées. Nous avons trouvé aussi que l’inhibition de ce processus par un inhibiteur pharmacologique diminue la réplication virale. L'autophagie est un processus physiologique cellulaire pendant lequel les vieux constituants cellulaires (mitochondries, protéines cellulaires, etc) se dégradent. Le fait que ce processus soit modulé dans les cellules dépendantes des différentes phases du cycle cellulaire, nous a poussé à l’étudier. Enfin, nous essayons d’investiguer la réplication virale dans les cellules dépourvues de p53, le gène suppresseur de tumeur, qui contrôle la progression de cycle cellulaire. Nous avons émis l’hypothèse suivante, que ces virus peuvent mieux se répliquer dans les cellules n’exprimant pas le gène p53. En vérifiant cette hypothèse, nous avons trouvé que l'inhibition de l’expression de p53 provoquée par siRNA ou par un agent pharmacologique conduit à une mort cellulaire massive dans une lignée de cellules T humaines ayant un gène p53 de type sauvage. Nous démontrons que cette mort se produit aussi dans une autre lignée cellulaire dont le p53 est muté et qu’elle pourrait être évitée par des inhibiteurs d'autophagie ou de nécroptose. Nos observations mettent en évidence qu’un niveau d’expression basale de p53 est nécessaire à la survie cellulaire.